PRKN and Alzheimer disease: Furthermore, a progressive reduction in Parkin expression was observed in both AD patient brains as well as mutant hAPP Tg mouse models, suggesting an impairment in effective activation of Parkin mediated mitophagy as the disease progressed (Ye et al., 2015).